BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

319 related articles for article (PubMed ID: 27196940)

  • 1. Chronic myelogenous leukaemia exosomes modulate bone marrow microenvironment through activation of epidermal growth factor receptor.
    Corrado C; Saieva L; Raimondo S; Santoro A; De Leo G; Alessandro R
    J Cell Mol Med; 2016 Oct; 20(10):1829-39. PubMed ID: 27196940
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chronic myeloid leukemia-derived exosomes promote tumor growth through an autocrine mechanism.
    Raimondo S; Saieva L; Corrado C; Fontana S; Flugy A; Rizzo A; De Leo G; Alessandro R
    Cell Commun Signal; 2015 Feb; 13():8. PubMed ID: 25644060
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Exosome-mediated crosstalk between chronic myelogenous leukemia cells and human bone marrow stromal cells triggers an interleukin 8-dependent survival of leukemia cells.
    Corrado C; Raimondo S; Saieva L; Flugy AM; De Leo G; Alessandro R
    Cancer Lett; 2014 Jun; 348(1-2):71-6. PubMed ID: 24657661
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multiple myeloma-derived exosomes are enriched of amphiregulin (AREG) and activate the epidermal growth factor pathway in the bone microenvironment leading to osteoclastogenesis.
    Raimondo S; Saieva L; Vicario E; Pucci M; Toscani D; Manno M; Raccosta S; Giuliani N; Alessandro R
    J Hematol Oncol; 2019 Jan; 12(1):2. PubMed ID: 30621731
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alteration of cellular and immune-related properties of bone marrow mesenchymal stem cells and macrophages by K562 chronic myeloid leukemia cell derived exosomes.
    Jafarzadeh N; Safari Z; Pornour M; Amirizadeh N; Forouzandeh Moghadam M; Sadeghizadeh M
    J Cell Physiol; 2019 Apr; 234(4):3697-3710. PubMed ID: 30317554
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Potential of Exosomes Derived from Chronic Myelogenous Leukaemia Cells as a Biomarker.
    Kang KW; Jung JH; Hur W; Park J; Shin H; Choi B; Jeong H; Kim DS; Yu ES; Lee SR; Sung HJ; Kim SJ; Choi CW; Kim HK; Hong S; Park JH; Choi Y; Park Y; Kim BS
    Anticancer Res; 2018 Jul; 38(7):3935-3942. PubMed ID: 29970515
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of exosomes released by chronic myelogenous leukemia cells in angiogenesis.
    Taverna S; Flugy A; Saieva L; Kohn EC; Santoro A; Meraviglia S; De Leo G; Alessandro R
    Int J Cancer; 2012 May; 130(9):2033-43. PubMed ID: 21630268
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Crosstalk between CML cells with HUVECS and BMSCs through CML derived exosomes.
    Cetin Z; Ilker Saygili E; Yilmaz M
    Front Biosci (Landmark Ed); 2021 Jan; 26(3):444-467. PubMed ID: 33049677
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Potential role of Notch signalling in CD34+ chronic myeloid leukaemia cells: cross-talk between Notch and BCR-ABL.
    Aljedai A; Buckle AM; Hiwarkar P; Syed F
    PLoS One; 2015; 10(4):e0123016. PubMed ID: 25849484
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Overexpression of heme oxygenase-1 in bone marrow stromal cells promotes microenvironment-mediated imatinib resistance in chronic myeloid leukemia.
    Liu P; Ma D; Yu Z; Zhe N; Ren M; Wang P; Yu M; Huang J; Fang Q; Wang J
    Biomed Pharmacother; 2017 Jul; 91():21-30. PubMed ID: 28445830
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alterations in the bone marrow microenvironment may elicit defective hematopoiesis: a comparison of aplastic anemia, chronic myeloid leukemia, and normal bone marrow.
    Park M; Park CJ; Cho YW; Jang S; Lee JH; Lee JH; Lee KH; Lee YH
    Exp Hematol; 2017 Jan; 45():56-63. PubMed ID: 27693387
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Exosomal shuttling of miR-126 in endothelial cells modulates adhesive and migratory abilities of chronic myelogenous leukemia cells.
    Taverna S; Amodeo V; Saieva L; Russo A; Giallombardo M; De Leo G; Alessandro R
    Mol Cancer; 2014 Jul; 13():169. PubMed ID: 25015105
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CML derived exosomes promote tumor favorable functional performance in T cells.
    Jafarzadeh N; Gholampour MA; Alivand MR; Kavousi S; Arzi L; Rad F; Sadeghizadeh M; Pornour M
    BMC Cancer; 2021 Sep; 21(1):1002. PubMed ID: 34493241
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chronic myelogenous leukemia cells remodel the bone marrow niche via exosome-mediated transfer of miR-320.
    Gao X; Wan Z; Wei M; Dong Y; Zhao Y; Chen X; Li Z; Qin W; Yang G; Liu L
    Theranostics; 2019; 9(19):5642-5656. PubMed ID: 31534508
    [No Abstract]   [Full Text] [Related]  

  • 15. Curcumin inhibits in vitro and in vivo chronic myelogenous leukemia cells growth: a possible role for exosomal disposal of miR-21.
    Taverna S; Giallombardo M; Pucci M; Flugy A; Manno M; Raccosta S; Rolfo C; De Leo G; Alessandro R
    Oncotarget; 2015 Sep; 6(26):21918-33. PubMed ID: 26116834
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased phosphorylation of eIF2α in chronic myeloid leukemia cells stimulates secretion of matrix modifying enzymes.
    Podszywalow-Bartnicka P; Cmoch A; Wolczyk M; Bugajski L; Tkaczyk M; Dadlez M; Nieborowska-Skorska M; Koromilas AE; Skorski T; Piwocka K
    Oncotarget; 2016 Nov; 7(48):79706-79721. PubMed ID: 27802179
    [TBL] [Abstract][Full Text] [Related]  

  • 17. BCR-ABL1-positive microvesicles malignantly transform human bone marrow mesenchymal stem cells in vitro.
    Fu FF; Zhu XJ; Wang HX; Zhang LM; Yuan GL; Chen ZC; Li QB
    Acta Pharmacol Sin; 2017 Nov; 38(11):1475-1485. PubMed ID: 28836580
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of bone marrow mesenchymal stem cells from blastic phase chronic myelogenous leukemia on the growth and apoptosis of leukemia cells.
    Han Y; Wang Y; Xu Z; Li J; Yang J; Li Y; Shang Y; Luo J
    Oncol Rep; 2013 Aug; 30(2):1007-13. PubMed ID: 23733230
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lack of evidence for abnormal autocrine or paracrine mechanisms underlying the uncontrolled proliferation of primitive chronic myeloid leukemia progenitor cells.
    Otsuka T; Eaves CJ; Humphries RK; Hogge DE; Eaves AC
    Leukemia; 1991 Oct; 5(10):861-8. PubMed ID: 1961020
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Expression of integrins in bone marrow mesenchymal stem cells derived from patients with chronic myeloid leukemia].
    Lu YL; Yu XQ; Zhu Y; Ba R; Zhu W; Xu WR
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2008 Aug; 16(4):755-8. PubMed ID: 18718054
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.